December 10, 2018 | blockescence plc: Portfolio company gamigo AG now listed with bond on Nasdaq Stockholm
Corporate news to the archive blockescence plc: Portfolio company gamigo AG now listed with bond on Nasdaq Stockholm Admission of bonds issued on October 11, 2018 to trading on Nasdaq Stockholm Use of proceeds for financing organic and M&A based growth, for refinancing existing debt and for other general corporate purposes Valletta, December 10, 2018: […]
Capital Market Panel H2/2018: Development of the German private equity market
cometis AG, one of Germany’s leading financial communication consultancies, has today published the results of its current Capital Market Panel. The survey for the second half of 2018 focuses on developments in the German private equity market. Managers at leading investment banks in Germany were surveyed for this purpose.
December 6, 2018 | blockescence plc.: Increase in Capital
Ad-hoc news to the archive blockescence plc.: Increase in Capital Valletta, December 6, 2018: blockescence plc (ISIN: MT0000580101, WKN: A1JGT0, Sym-bol: BCK) informs that its Board of Directors has decided to increase the company’s share capital. The Company issues 500,000 new common shares with a nominal value of EUR 1.00 per share from its Authorized […]
December 5, 2018 | KROMI holds successful 2018 AGM
Corporate news to the archive KROMI holds successful 2018 AGM Hamburg, December 5, 2018 – KROMI Logistik AG, a manufacturer-independent expert in optimising tool availability and tool deployment in machining operations, successfully held its 2018 Annual General Meeting today, Wednesday. The presence of attended share capital amounted to 88.62%, and all agenda items were approved. […]
November 23, 2018 | creditshelf continues growth course in the third quarter of 2018
Corporate News to the archive creditshelf continues growth course in the third quarter of 2018 Revenues in the first nine months of 2018 up 127.1% on the prior-year period to EUR 1.55 million Loan requests in the third quarter remain high at EUR 243.2 million Loan volume brokered nearly doubled figure from June 30, 2018 […]
22 November 2018 | DEAG continues profitable growth, raises forecast for 2018
Corporate News to the archive DEAG continues profitable growth, raises forecast for 2018 Group revenue increased by 41 % over last year to EUR 153 million in the first nine months (previous year: EUR 108 million) Group EBIT rose by EUR 651 % over last year to EUR 8.2 million in the first nine months […]
November 21, 2018 | CORESTATE’s Hannover Leasing launches closed-end property AIF investing in office/hotel/asset
Corporate news to the archive CORESTATE’s Hannover Leasing launches closed-end property AIF investing in office/hotel/asset Pullach, 21 November 2018 – Hannover Leasing, part of the CORESTATE Group, has launched a new closed-end property AIF for private investors. The fund invests in the property named Quartier West, an office and hotel complex with 14,963 sqm of […]
November 20, 2018 | Dermapharm Holding SE reports positive business development in the third quarter of 2018
Dr. Hans-Georg Feldmeier, CEO of Dermapharm Holding SE, comments: “In the first nine months of 2018, we continued our positive business development, including our successful admission to the Prime Standard of the Frankfurt Stock Exchange, the integration of recent acquisitions as well as the successful introduction of in-house developments.
November 18, 2018 | Dermapharm Holding SE: Signing of contract for the acquisition of EUROMED S.A.
Corporate News to the archive Dermapharm Holding SE: Signing of contract for the acquisition of EUROMED S.A. Grünwald, November 18, 2018 – Dermapharm Holding SE (ISIN: DE000A2GS5D8), a leading manufacturer of patent-free branded pharmaceuticals for selected therapeutic areas in Germany with a growing international presence, today signed an agreement to acquire the Spanish company EUROMED […]
November 16, 2018 | Dermapharm takes legal action against approval of a competitor product
Corporate news to the archive Dermapharm takes legal action against approval of a competitor product Grünwald, November 16, 2018 – Dermapharm Holding SE (WKN A2GS5D, ISIN DE000A2GS5D8), a leading manufacturer of patent-free branded pharmaceuticals for selected therapeutic areas in Germany with a growing international presence, is taking legal action against the approval of the generic […]